Showing results (361-370 of 635) with videos related to

Sort By:
Pageof 64
Thyroid : Official Journal of the American Thyroid Association|May 14, 2019
Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and TreatmentAnne R Cappola, Akshay S Desai, Marco Medici, et al.
Circulation. Heart Failure|March 16, 2019
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation StatusSøren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
Journal of Cardiac Failure|November 28, 2024
Integration of Palliative Care into Heart Failure Care: Consensus-Based Recommendations from the Heart Failure Society of AmericaSarah Chuzi, Martha Abshire Saylor, Larry A Allen, et al.
JACC. Heart Failure|July 5, 2023
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/ValsartanJames P Curtain, Carly Adamson, Kieran F Docherty, et al.
The American Journal of Cardiology|October 25, 2016
Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart FailureLeo F Buckley, Enrique Seoane-Vazquez, Judy W M Cheng, et al.
Circulation. Heart Failure|March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection FractionMingming Yang, Toru Kondo, Pooja Dewan, et al.
JAMA Cardiology|August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical TrialPeder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation. Heart Failure|February 18, 2020
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection FractionRasmus Rørth, Pardeep S Jhund, Mehmet B Yilmaz, et al.
JACC. Heart Failure|November 30, 2019
Influence of Age on Efficacy and Safety of Spironolactone in Heart FailureOrly Vardeny, Brian Claggett, Muthiah Vaduganathan, et al.
Pageof 64